AR018260A1 - A PROCESS TO PREPARE A GAMMAGLOBULIN SOLUTION THAT CAN BE ADMINISTERED INTRAVENOUSLY, AND GAMMAGLOBULIN SOLUTION OBTAINED BY DICHOPROCESS - Google Patents

A PROCESS TO PREPARE A GAMMAGLOBULIN SOLUTION THAT CAN BE ADMINISTERED INTRAVENOUSLY, AND GAMMAGLOBULIN SOLUTION OBTAINED BY DICHOPROCESS

Info

Publication number
AR018260A1
AR018260A1 ARP980106616A ARP980106616A AR018260A1 AR 018260 A1 AR018260 A1 AR 018260A1 AR P980106616 A ARP980106616 A AR P980106616A AR P980106616 A ARP980106616 A AR P980106616A AR 018260 A1 AR018260 A1 AR 018260A1
Authority
AR
Argentina
Prior art keywords
gammaglobulin
administered intravenously
dichoprocess
prepare
gammaglobulin solution
Prior art date
Application number
ARP980106616A
Other languages
Spanish (es)
Original Assignee
Alpha Therapeutic Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha Therapeutic Corp filed Critical Alpha Therapeutic Corp
Publication of AR018260A1 publication Critical patent/AR018260A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Un proceso para producir una solucion de gammaglobulina que puede ser administrada por vía intravenosa, sustancialmente libre de virus contaminantes,mediante el tratamiento con calor para inactivacion viral y fraccionamiento de una solucion de gammaglobulina impura y luego tratando la gammagloblulinapurificada con un solvente-detergente para inactivacion viral adicional. Solucion de gammaglobulina obtenida por dicho proceso.A process for producing a gamma globulin solution that can be administered intravenously, substantially free of contaminating viruses, by heat treatment for viral inactivation and fractionation of an impure gamma globulin solution and then treating the purified gamma globulin with a solvent-detergent for inactivation. additional viral. Gammaglobulin solution obtained by said process.

ARP980106616A 1997-12-24 1998-12-22 A PROCESS TO PREPARE A GAMMAGLOBULIN SOLUTION THAT CAN BE ADMINISTERED INTRAVENOUSLY, AND GAMMAGLOBULIN SOLUTION OBTAINED BY DICHOPROCESS AR018260A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99795297A 1997-12-24 1997-12-24

Publications (1)

Publication Number Publication Date
AR018260A1 true AR018260A1 (en) 2001-11-14

Family

ID=25544595

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980106616A AR018260A1 (en) 1997-12-24 1998-12-22 A PROCESS TO PREPARE A GAMMAGLOBULIN SOLUTION THAT CAN BE ADMINISTERED INTRAVENOUSLY, AND GAMMAGLOBULIN SOLUTION OBTAINED BY DICHOPROCESS

Country Status (15)

Country Link
EP (1) EP0971727A4 (en)
JP (1) JP2001514672A (en)
KR (1) KR20000075562A (en)
CN (1) CN1214042C (en)
AR (1) AR018260A1 (en)
AU (1) AU747893B2 (en)
BR (1) BR9807598A (en)
CA (1) CA2281938A1 (en)
CO (1) CO4970799A1 (en)
IL (1) IL131471A0 (en)
MY (1) MY117328A (en)
RU (1) RU2198668C2 (en)
TW (1) TW546144B (en)
UA (1) UA64742C2 (en)
WO (1) WO1999033484A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2527915T3 (en) 1998-06-09 2015-02-02 Csl Behring Ag Liquid immunoglobulin G (IgG) product
EP1185290A4 (en) * 1999-06-15 2005-08-31 Alpha Therapeutic Corp Manufacturing method for intravenous immune globulin and resultant product
JP2004525077A (en) * 2000-09-28 2004-08-19 リサーチ　コーポレイション　テクノロジーズ，インコーポレイテッド Treatment of immune-mediated diseases by oral administration of immunoglobulin G enriched plasma fraction
ES2184594B1 (en) * 2001-01-17 2004-01-01 Probitas Pharma Sa PROCEDURE FOR THE PRODUCTION OF GAMMAGLOBULINA G HUMANA INACTIVADA OF VIRUS.
US6893639B2 (en) 2001-10-19 2005-05-17 Hemacare Corporation Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
ES2558303T3 (en) 2002-09-11 2016-02-03 Chugai Seiyaku Kabushiki Kaisha Protein Purification Method
TWI320788B (en) 2005-05-25 2010-02-21 Hoffmann La Roche Method for the purification of antibodies
KR100791502B1 (en) * 2006-09-29 2008-01-03 한스바이오메드 주식회사 Production methods of virus inactivated and cell-free body implant
EP2350271B1 (en) * 2008-11-20 2016-01-27 Biogen MA Inc. Arginine inactivation of enveloped viruses
IL212911A0 (en) * 2011-05-16 2011-07-31 Omrix Biopharmaceuticals Ltd Immunoglobulin reduced in thrombogenic contaminants and preparation thereof
ES2381828B1 (en) * 2012-03-20 2012-11-16 Grifols, S.A. PROCEDURE TO OBTAIN A COMPOSITION OF IgG THROUGH THERMAL TREATMENT
ES2785375T3 (en) 2014-03-11 2020-10-06 Green Cross Holdings Corp Immunoglobulin purification procedure
CN107880116B (en) * 2016-09-30 2023-02-03 盖立复集团公司 Method for producing immunoglobulins

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (en) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Method of Obtaining IV Compatible Gamma Globulins
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
US4835257A (en) * 1984-07-07 1989-05-30 Armour Pharma Gmbh Process for preparing gamma globulin suitable for intravenous administration using peg and a citrate buffer
FR2582515B1 (en) * 1985-05-30 1988-11-04 Merieux Inst PROCESS FOR THE PREPARATION OF GAMMA-GOBULINS ADMINISTRABLE BY THE INTRAVENOUS ROUTE AND GAMMA-GLOBULINS OBTAINED
JPH0662436B2 (en) * 1986-05-19 1994-08-17 株式会社ミドリ十字 Method for producing intravenous immunoglobulin preparation
US4841023A (en) * 1986-06-25 1989-06-20 New York Blood Center, Inc. Inactivation of viruses in labile protein-containing compositions using fatty acids
DE3825429C2 (en) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Method for producing an intravenously administrable polyclonal immunoglobulin preparation with a high IgM content
JP2965069B2 (en) * 1989-01-13 1999-10-18 吉富製薬株式会社 Method for producing protein-containing composition
EP0378208B2 (en) * 1989-01-13 2003-01-15 Mitsubishi Pharma Corporation Production method for protein-containing composition
CA2034489C (en) * 1989-06-15 1996-07-16 Michael E. Hrinda Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
US5177194A (en) * 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
JP3145696B2 (en) * 1990-10-05 2001-03-12 日本ケミカルリサーチ株式会社 Method for producing secretory immunoglobulin A preparation
US5110910A (en) * 1991-03-25 1992-05-05 Miles Inc. Virucidal euglobulin precipitation
DE4431833C1 (en) * 1994-09-07 1995-05-18 Blutspendedienst Der Drk Lande Prepn. of an anti-haemophilic factor from a cryo-precipitate
JP4003235B2 (en) * 1994-09-30 2007-11-07 三菱ウェルファーマ株式会社 Method for producing intravenous immunoglobulin preparation

Also Published As

Publication number Publication date
WO1999033484A1 (en) 1999-07-08
CN1252729A (en) 2000-05-10
KR20000075562A (en) 2000-12-15
EP0971727A1 (en) 2000-01-19
IL131471A0 (en) 2001-01-28
MY117328A (en) 2004-06-30
TW546144B (en) 2003-08-11
CA2281938A1 (en) 1999-07-08
JP2001514672A (en) 2001-09-11
AU1703899A (en) 1999-07-19
UA64742C2 (en) 2004-03-15
RU2198668C2 (en) 2003-02-20
AU747893B2 (en) 2002-05-30
BR9807598A (en) 2000-02-22
CN1214042C (en) 2005-08-10
CO4970799A1 (en) 2000-11-07
EP0971727A4 (en) 2005-01-19

Similar Documents

Publication Publication Date Title
AR018260A1 (en) A PROCESS TO PREPARE A GAMMAGLOBULIN SOLUTION THAT CAN BE ADMINISTERED INTRAVENOUSLY, AND GAMMAGLOBULIN SOLUTION OBTAINED BY DICHOPROCESS
ES2057191T5 (en) PRODUCTION METHOD FOR A COMPOSITION CONTAINING PROTEINS.
ES2148332T3 (en) PROCEDURE FOR THE PRODUCTION OF IMMUNOGLOBULIN CONCENTRATE G.
CO4960659A1 (en) VACCINE INCLUDING AN ANTIGEN FOR HEPATITIS B VIRUSES AND AN ANTIGEN FOR HERPES SIMPLEX VIRUS
ATE54828T1 (en) TREATMENT OF BIOLOGICAL AND PHARMACEUTICAL PRODUCTS ADOPTED ON A SOLID PHASE WITH VIRAL AND PYROGENIC INACTIVATING AGENTS.
EP1852121A3 (en) Lipid analogs for treating viral infections
DE69830751D1 (en) Polyaromatic compounds for the treatment of herpes infections
NO177526C (en) Process for the preparation of pharmaceutically active conjugates
ES2075843T3 (en) PRODUCTION METHOD OF A CERAMIC SUPERCONDUCTOR WIRE.
ES2138603T3 (en) PROCEDURE FOR THE ISOLATION OF FACTORS IX, X AND II HIGHLY PURIFIED FROM THE PROTO-COMBIN COMPLEX OR THE HUMAN PLASMA.
BR0010815A (en) Method of preparing viral doubly inactivated immune globulin for intravenous administration
ES2140652T3 (en) USE OF N-ALKYL-DERIVATIVES OF 1,5-DIDESOXI-1,5-IMINO-D-GLUCITOL FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTIONS.
MX9203011A (en) PROCEDURE FOR PREPARING AN AQUEOUS VON WILLEBRAND FACTOR FRAGMENT SOLUTION ALTERED WITH CYSTEINE AND THERAPEUTIC SOLUTION FUSED THROUGH THE SAME
NO931476L (en) PROCEDURE FOR MANUFACTURING A VIRUS SAFE, HIGHLY FACTOR VIII
ES2053684T3 (en) PROCEDURE TO PREPARE A HIGHLY PURE, NON-INFECTIOUS ANTIHEMOPHILIC FACTOR THROUGH CHROMATOGRAPHY.
ATE235915T1 (en) TREATMENT OF HEMORRHAGIC VIRUS FEVER WITH PROTEIN C
ES2118386T3 (en) PROCEDURE FOR THE INACTIVATION OF VIRUSES THAT ARE NOT PROVIDED WITH LIPID ENVELOPES.
EA200100133A1 (en) OXAZOLIDINONES FOR THE TREATMENT OF INFECTIOUS EYE DISEASES
ES2086359T3 (en) R (-) - 1- (5-HIDROXIHEXIL) -3-METHYL-7-PROPYLXANTINE, PROCEDURE FOR ITS PREPARATION AND MEDICINES CONTAINING THIS COMPOUND.
BR0011648A (en) Manufacturing method of intravenous immunoglobulin and resulting product
ATE247474T1 (en) USE OF INOSITE TRIPHOSPHATE FOR PRODUCING MEDICINAL PRODUCTS
ES2053606T3 (en) PREPARATION METHOD OF A HIGH PURITY ALPHA-1-PROTEINASE INHIBITOR.
ES2182846T3 (en) PROCEDURE FOR THE PREPARATION OF A FRACTION CONTAINING FACTOR VIII, DEACTIVATED AS TO VIRUSES, BY METHODS OF CHROMATOGRAPHY.
MX9201288A (en) TREATMENT METHOD.
NO912387D0 (en) PURE FACTOR 1 PROTEIN, AND PROCEDURE FOR PRODUCING THE PROTEIN.

Legal Events

Date Code Title Description
FB Suspension of granting procedure